Prognostic factors in conversion surgery following nab‐paclitaxel with gemcitabine and subsequent chemoradiotherapy for unresectable locally advanced pancreatic cancer: Results of a dual‐center study

Prognostic factors in conversion surgery following nab‐paclitaxel with gemcitabine and subsequent chemoradiotherapy for unresectable locally advanced pancreatic cancer: Results of a dual‐center study

Abstract Background In pancreatic ductal adenocarcinoma (PDAC), only radical surgery improves long‐term survival. We focused on surgical outcome after induction gemcitabine along with nab‐paclitaxel (GnP) and subsequent chemoradiotherapy (CRT) with S‐1 administration for unresectable locally advance...

Full description

Bibliographic Details
Main Authors: Takamichi Igarashi, Suguru Yamada, Yui Hoshino, Kenta Murotani, Hayato Baba, Hideki Takami, Isaku Yoshioka, Kazuto Shibuya, Yasuhiro Kodera, Tsutomu Fujii
Format: Article
Language:English
Published: Wiley 2023-01-01
Series:Annals of Gastroenterological Surgery
Subjects:
chemoradiotherapy
chemotherapy
pancreatic cancer
prognostic factor
unresectable locally advanced
Online Access:https://doi.org/10.1002/ags3.12613

Internet

https://doi.org/10.1002/ags3.12613

Similar Items